Regeneron Pharma begins human trials of Covid-19 antibody ‘cocktail’
Team Udayavani, Jun 13, 2020, 10:03 AM IST
US-based Regeneron Pharmaceuticals has begun human trials of its antibody ‘cocktail’ as a treatment for Covid-19
The antibody which is called REGN-COV2, contains an antibody made by Regeneron and a second isolated from humans who recovered from Covid-19.
George Yancopoulos .Chief Scientific Officer, said“If it goes perfectly well, within a week or two we will move to the second phase. Within a month or so of that we will have clear data that this is or isn’t working. By the end of summer, we could have sufficient data for broad utilization”
Regeneron said its treatment could be useful even if a Covid-19 vaccine is developed since the elderly and people with compromised immune systems often do not respond well to vaccines.
The firm also plans to study REGN-COV2 for preventing the infection in people at high risk of exposure.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
MUST WATCH
Latest Additions
Rs 20.14 cr unaccounted cash seized in poll run up in Karnataka
HC grants bail to man held for sexually assaulting ‘friend’ at Mumbai beach in 2021
Congress’s Kolar conundrum remains unsolved despite CM, DCM attempt to quell dissent
Mangaluru: Illegal slaughterhouse raided by police, Three arrested
‘No evidence of wrongdoing’: CBI closes UPA-era Air India aircraft leasing